GPT Healthcare Ltd

GPT Healthcare Ltd., a small-cap hospital operator with a market capitalisation of ₹1,195 crores, reported a concerning decline in profitability for Q2 FY26, despite posting its highest-ever quarterly revenue. Net profit fell 28.49% quarter-on-quarter to ₹10.60 crores, whilst declining 28.48% year-on-year from ₹14.82 crores in Q2 FY25. The stock, trading at ₹147.35 as of November 7, 2025, has struggled throughout the year, declining 19.39% year-to-date and underperforming both the benchmark Sensex and its hospital sector peers by significant margins.

GPT Healthcare, a small-cap hospital industry player, has recently revised its evaluation amid market challenges. The stock has experienced a year-long decline, contrasting with broader market gains. Technical indicators suggest a bearish sentiment, while the stock has shown stability over the past month despite significant volatility in its 52-week range.

GPT Healthcare, a small-cap hospital industry player, has seen its stock price rise slightly to 149.05. Over the past year, it has faced challenges with a return of -13.84%. Technical indicators show mixed signals, reflecting volatility and a recent monthly return of 0.78% compared to the Sensex's 3.41%.

GPT Healthcare, a small-cap hospital industry player, has recently revised its evaluation amid challenging market conditions. The stock has experienced a significant decline over the past year, underperforming compared to the Sensex. Technical indicators suggest a bearish sentiment, reflecting cautious market sentiment surrounding the company's performance.

GPT Healthcare has recently undergone an evaluation adjustment, reflecting changes in technical trends and indicators. The company reported a significant decline in net profit for the quarter ending June 2025, alongside a decrease in institutional investor participation and a low return on capital employed, highlighting concerns about its market position.

GPT Healthcare, a small-cap hospital industry player, has recently encountered a Death Cross, indicating potential bearish momentum. With a market capitalization of Rs 1,206.00 crore and a P/E ratio significantly below the industry average, the stock has underperformed over the past year, facing ongoing challenges despite a slight recent increase.

GPT Healthcare, a small-cap hospital industry player, has recently revised its evaluation amid challenging market conditions. The stock has experienced a significant decline over the past year, underperforming compared to the Sensex. Technical indicators present a mixed outlook, emphasizing the need for stakeholders to monitor the company's strategies closely.

GPT Healthcare has recently adjusted its evaluation score, reflecting a shift in technical trends. The company has faced challenges over the past year, with a return of -14.87%, despite a modest profit increase. Financial metrics indicate high management efficiency, but recent performance has been inconsistent.